• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:一例具有侵袭性转化的黏液样软骨肉瘤患者复发和转移病灶中的基因异质性

Case Report: Gene Heterogeneity in the Recurrent and Metastatic Lesions of a Myxoid Chondrosarcoma Patient With Aggressive Transformation.

作者信息

He Xuanhong, Wang Yitian, Zou Chang, Zheng Chuanxi, Luo Yi, Zhou Yong, Tu Chongqi

机构信息

Department of Orthopedics, Orthopedics Research Institute, West China Hospital, Sichuan University, Chengdu, China.

Bone and Joint 3D-Printing & Biomechanical Laboratory, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Genet. 2022 Jul 14;13:791675. doi: 10.3389/fgene.2022.791675. eCollection 2022.

DOI:10.3389/fgene.2022.791675
PMID:35910216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9330136/
Abstract

Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue sarcoma. In view of the indolent course throughout the prolonged natural history of EMC, it was considered as a low-grade soft-tissue sarcoma. However, recent studies have revealed a high recurrence and metastatic potential in EMC, and the invasiveness of EMC may progress during the protracted clinical course. The mechanism for this aggressive transformation remains unknown. Here, we present a rare case of EMC with aggressive behavior. This case was confirmed pathology and NR4A3 fluorescent hybridization. To verify the genetic characteristics of this rare case, a total gene sequencing analyses was performed in the recurrent and metastatic lesions. Intriguingly, different gene mutations were determined in the recurrent and metastatic lesions, which implied the genetic heterogeneity among the different lesions might be related to the aggressiveness of EMC. Furthermore, we discuss a few potential agents against the mutated genes in this case, which may provide novel insights regarding the targeted therapy of EMC.

摘要

骨外黏液样软骨肉瘤(EMC)是一种罕见的软组织肉瘤。鉴于EMC在漫长自然病程中的惰性病程,它曾被视为一种低级别软组织肉瘤。然而,最近的研究显示EMC具有高复发和转移潜能,并且EMC的侵袭性可能在漫长的临床病程中进展。这种侵袭性转变的机制仍然未知。在此,我们报告一例具有侵袭性行为的罕见EMC病例。该病例经病理及NR4A3荧光杂交确诊。为验证这一罕见病例的基因特征,对复发和转移病灶进行了全基因测序分析。有趣的是,在复发和转移病灶中确定了不同的基因突变,这表明不同病灶间的基因异质性可能与EMC的侵袭性有关。此外,我们讨论了针对该病例中突变基因的几种潜在药物,这可能为EMC的靶向治疗提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/9330136/7059d08078a5/fgene-13-791675-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/9330136/25e07ac463db/fgene-13-791675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/9330136/f1cbf198d91c/fgene-13-791675-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/9330136/a0c146dffcee/fgene-13-791675-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/9330136/5049d3e6f3d4/fgene-13-791675-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/9330136/7059d08078a5/fgene-13-791675-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/9330136/25e07ac463db/fgene-13-791675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/9330136/f1cbf198d91c/fgene-13-791675-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/9330136/a0c146dffcee/fgene-13-791675-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/9330136/5049d3e6f3d4/fgene-13-791675-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e6/9330136/7059d08078a5/fgene-13-791675-g005.jpg

相似文献

1
Case Report: Gene Heterogeneity in the Recurrent and Metastatic Lesions of a Myxoid Chondrosarcoma Patient With Aggressive Transformation.病例报告:一例具有侵袭性转化的黏液样软骨肉瘤患者复发和转移病灶中的基因异质性
Front Genet. 2022 Jul 14;13:791675. doi: 10.3389/fgene.2022.791675. eCollection 2022.
2
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.NR4A3 融合蛋白触发轴突导向开关,标志着 EWSR1 和 TAF15 易位的骨外黏液样软骨肉瘤之间的差异。
J Pathol. 2019 Sep;249(1):90-101. doi: 10.1002/path.5284. Epub 2019 May 14.
3
Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report.利用EWSR1-NR4A3基因融合诊断大腿部骨外黏液样软骨肉瘤:一例报告
J Med Case Rep. 2016 Nov 10;10(1):321. doi: 10.1186/s13256-016-1113-2.
4
Pulmonary extraskeletal myxoid chondrosarcoma: A case report and literature review.肺外骨骼黏液样软骨肉瘤:一例报告及文献复习
Int J Surg Case Rep. 2016;27:96-101. doi: 10.1016/j.ijscr.2016.08.025. Epub 2016 Aug 26.
5
A case of highly aggressive extraskeletal myxoid chondrosarcoma.一例高侵袭性骨外黏液样软骨肉瘤病例。
Case Rep Oncol. 2011 May;4(2):377-84. doi: 10.1159/000331237. Epub 2011 Aug 17.
6
Periosteal Myxoid Leiomyosarcoma Histologically Mimicking Extraskeletal Myxoid Chondrosarcoma: Report of a Case with Histopathological and Cytopathological Comparison with Extraskeletal Myxoid Chondrosarcoma.骨膜黏液样平滑肌肉瘤组织学上类似于骨外黏液样软骨肉瘤:一例与骨外黏液样软骨肉瘤的组织病理学和细胞病理学比较的报告。
Acta Cytol. 2021;65(6):541-548. doi: 10.1159/000518004. Epub 2021 Sep 20.
7
Fine-needle aspiration features of extraskeletal myxoid chondrosarcoma: A study of cytological and molecular features.骨外黏液样软骨肉瘤的细针穿刺特征:细胞学和分子特征研究
Diagn Cytopathol. 2018 Nov;46(11):950-957. doi: 10.1002/dc.24028. Epub 2018 Oct 24.
8
Next generation sequencing of extraskeletal myxoid chondrosarcoma.骨外黏液样软骨肉瘤的下一代测序
Oncotarget. 2017 Mar 28;8(13):21770-21777. doi: 10.18632/oncotarget.15568.
9
A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.骨外黏液样软骨肉瘤中的一种新型融合变异 LSM14A::NR4A3。
Genes Chromosomes Cancer. 2023 Jan;62(1):52-56. doi: 10.1002/gcc.23090. Epub 2022 Aug 22.
10
Whole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma.全基因组测序用于检测骨外黏液样软骨肉瘤转移灶的突变负荷
Front Mol Med. 2023 Jul 24;3:1152550. doi: 10.3389/fmmed.2023.1152550. eCollection 2023.

本文引用的文献

1
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC.表皮生长因子受体(EGFR)高拷贝数联合高 EGFR 蛋白表达预示着西妥昔单抗为基础的治疗在鳞状细胞肺癌中的获益改善:来自 SWOG S0819 的分析,这是一项晚期 NSCLC 中化疗联合或不联合西妥昔单抗的 III 期临床试验。
Clin Lung Cancer. 2022 Jan;23(1):60-71. doi: 10.1016/j.cllc.2021.10.002. Epub 2021 Oct 10.
2
The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.FBXW7-NOTCH 相互作用组:一种泛素蛋白酶体系统诱导的串扰调节人类组织中的致癌转化。
Cancer Rep (Hoboken). 2021 Aug;4(4):e1369. doi: 10.1002/cnr2.1369. Epub 2021 Apr 6.
3
Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features.转移性结直肠癌的全基因组测序揭示了既往治疗效果和特定转移特征。
Nat Commun. 2021 Jan 25;12(1):574. doi: 10.1038/s41467-020-20887-6.
4
Extraskeletal Myxoid Chondrosarcoma: State of the Art and Current Research on Biology and Clinical Management.骨外黏液样软骨肉瘤:生物学与临床管理的最新进展及当前研究
Cancers (Basel). 2020 Sep 21;12(9):2703. doi: 10.3390/cancers12092703.
5
Extraskeletal Myxoid Chondrosarcoma: Clinical and Molecular Characteristics and Outcomes of Patients Treated at Two Institutions.骨外黏液样软骨肉瘤:两家机构治疗患者的临床、分子特征及预后
Front Oncol. 2020 Jun 16;10:828. doi: 10.3389/fonc.2020.00828. eCollection 2020.
6
Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group.骨外黏液样软骨肉瘤的分子诊断:意大利肉瘤研究组的一项多中心回顾性研究。
Ann Surg Oncol. 2021 Feb;28(2):1142-1150. doi: 10.1245/s10434-020-08737-7. Epub 2020 Jun 22.
7
Low expression of the ubiquitin ligase FBXW7 correlates with poor prognosis of patients with colorectal cancer.泛素连接酶FBXW7的低表达与结直肠癌患者的不良预后相关。
Int J Clin Exp Pathol. 2018 Jan 1;11(1):413-419. eCollection 2018.
8
Extraskeletal Myxoid Chondrosarcoma of the Midfoot Presenting as Charcot Arthropathy: A Case Report.表现为夏科氏关节病的中足骨外黏液性软骨肉瘤:一例报告
JBJS Case Connect. 2019 Dec;9(4):e0458. doi: 10.2106/JBJS.CC.18.00458.
9
Genomic Profiling of Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents.野生型转移性结直肠癌患者的基因组分析揭示了可能与抗EGFR药物耐药相关基因中的新突变。
Cancers (Basel). 2019 Jun 20;11(6):859. doi: 10.3390/cancers11060859.
10
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.NR4A3 融合蛋白触发轴突导向开关,标志着 EWSR1 和 TAF15 易位的骨外黏液样软骨肉瘤之间的差异。
J Pathol. 2019 Sep;249(1):90-101. doi: 10.1002/path.5284. Epub 2019 May 14.